Genetic Testing in Anencephaly
Genetic testing is not routinely necessary for isolated anencephaly, but chromosomal microarray analysis (CMA) should be offered when anencephaly is diagnosed prenatally, particularly if additional structural anomalies are present or if there is a family history of neural tube defects.
Primary Diagnostic Approach
The diagnosis of anencephaly is primarily established through ultrasound examination and maternal serum alpha-fetoprotein (AFP) screening, not genetic testing 1. Anencephaly can be detected in all cases during first-trimester ultrasound screening, and early diagnosis is recommended to allow for optimal pregnancy management 2.
When to Consider Genetic Testing
Chromosomal Analysis is Indicated When:
Additional structural anomalies are present: Anencephaly can be associated with chromosomal abnormalities, particularly trisomy 18 3. When multiple anomalies are identified on prenatal ultrasound, chromosomal microarray analysis (CMA) is the recommended first-line diagnostic test 4.
Fetal karyotyping should be performed if anencephaly is suspected in conjunction with other malformations, as documented cases show co-occurrence with aneuploidy 3.
Parental Genetic Testing for Recurrence Risk:
Folate metabolism gene analysis should be considered in parents, particularly testing for:
This testing is especially relevant when there is a positive family history of neural tube defects or for counseling about recurrence risk in future pregnancies 3.
Understanding the Etiology
Most cases of anencephaly are sporadic with multifactorial inheritance 1. The condition is not typically caused by a single identifiable genetic mutation, but rather results from:
- Environmental factors (folate deficiency, anticonvulsant medications like valproate, maternal diabetes, obesity)
- Genetic polymorphisms affecting folate metabolism
- Rarely, single gene disorders or chromosomal abnormalities 1, 2
Important Clinical Caveats
Conventional karyotyping may be more appropriate than CMA when a common aneuploidy (such as trisomy 18) is strongly suspected based on the constellation of findings 5. CMA should not be used when rapid turnaround time is critical, as conventional karyotyping can be completed within 48 hours 5.
Autopsy should be performed in all cases of early ultrasound-based diagnosis of fetal malformations, including anencephaly, to confirm the diagnosis and identify any additional abnormalities that may inform recurrence risk 3.
Prevention Focus Over Diagnosis
Since anencephaly is 100% fatal (resulting in miscarriage, stillbirth, or death within hours to days after birth) 2, the emphasis should be on prevention through preconceptional folic acid supplementation, which can reduce neural tube defect incidence by up to 80% 1, 6. Genetic counseling should focus on recurrence risk and prevention strategies for future pregnancies rather than extensive genetic workup of the affected pregnancy unless additional anomalies suggest an underlying chromosomal disorder.